BROWSE·page 33 of 44

Browse EX-10 agreements

526 matching material contract exhibits.


EX-10.1

EX-10.1

EXECUTION VERSION

AMENDMENT NO. 1 TO GUARANTEE AGREEMENT

AMENDMENT NO. 1 TO GUARANTEE AGREEMENT, dated as of May 14, 2026 (this

“Amendment”), between LUMENT FINANCE TRUST, INC., a Maryland corporation (the “Guarantor”) and JPMORGAN CHASE BANK, NATIONAL ASSOCIATION, a national banking association (the “Buyer”) and agreed and acknowledged by LCMT WAREHOUSE, LLC, a Delaware limited liability company (the “Seller”) solely with respect to Sections 2 and 4. Capitalized terms used but not otherwise defined herein shall have the meanings given to them in the Guarantee Agreement (as defined below).

RECITALS

WHEREAS, the Guarantor and Buyer are parties to that certain Guarantee Agreement, dated as of November 3, 2025 (as amended hereby and as further amended, restated, supplemented or otherwise modified and in effect from time to time, the “Guarantee”);

WHEREAS, the Seller and Buyer are parties to that certain Master Repurchase Agreement, dated as of November 3, 2025 (as amended, restated, supplemented or otherwise modified from time to time, the “Repurchase Agreement”);

EX-10.1·10-Q·CIK 1547546·ACC 0001547546-26-000012·Filed May 17, 2026, 15:12 EDT

EX-10.3

EX-10.3

Exhibit 10.3

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL. [***] INDICATES THAT INFORMATION HAS BEEN REDACTED.

March 16th 2026

Awaysis Belize Limited

3301 Chetumal Street

Belize City, Belize

Guarantors: Yacht Club Resorts development Company Limited, Mr. Michael Singh, Mr. Andrew Trumbach

Dear Clients,

The Belize Bank Limited hereinafter referred to as the “Bank”) is pleased to advise that we will make available to Awaysis Belize Limited (the “Borrower”), the following credit facility/facilities on the terms and conditions outlined below and in Schedule A (General Terms and Conditions), Schedule B (Conditions Precedent), Schedule C (Security Documents), and Schedule D (Form of Acceptance) of this facility letter agreement (hereinafter this facility letter together with Schedule A, Schedule B, Schedule C and Schedule D shall collectively be referred to as “the Agreement”):

CREDIT A: Loan Facility

EX-10.3·10-Q·CIK 1021917·ACC 0001493152-26-023863·Filed May 17, 2026, 15:11 EDT

EX-10.4

EX-10.4

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS. THIS SECURITY AND THE SECURITIES ISSUABLE UPON EXERCISE OF THIS SECURITY MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN SECURED BY SUCH SECURITIES.

COMMON STOCK PURCHASE WARRANT

brainstorm cell therapeutics inc.

Warrant Shares: Issue Date: , 2026

EX-10.4·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.3

EX-10.3

Exhibit 10.3

SECURITIES PURCHASE AGREEMENT

This Securities Purchase Agreement (this “Agreement”) is dated as of May ___, 2026 between Brainstorm Cell Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an exemption from the registration requirements of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and/or Regulation D thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser, severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

ARTICLE I.

EX-10.3·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.2

EX-10.2

THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.

THE ISSUE PRICE OF THIS NOTE IS $151,800.00

THE ORIGINAL ISSUE DISCOUNT IS $19,800.00

Principal Amount: $151,800.00****Purchase Price: $132,000.00 Issue Date: May 11, 2026

PROMISSORY NOTE

EX-10.2·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.1

EX-10.1

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of May 11, 2026, by and between BRAINSTORM CELL THERAPEUTICS INC., a Delaware corporation, with its address at 1325 Avenue of Americas, 28th Floor, New York, New York 10019 (the “Company”), and Vanquish Funding Group Inc., a Virginia corporation, with its address at 1800 Diagonal Road, Suite 623, Alexandria VA 22314 (the “Buyer”).

WHEREAS:

A.The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”); and

EX-10.1·10-Q·CIK 1137883·ACC 0001104659-26-062648·Filed May 17, 2026, 15:11 EDT

EX-10.2

EX-10.2

PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED BECAUSE THEY ARE BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. INFORMATION THAT HAS BEEN OMITTED HAS BEEN NOTED IN THIS DOCUMENT WITH A PLACEHOLDER IDENTIFIED BY THE MARK “[***]”

Execution Version













Amendment Deed



Corporate Markets Loan & Bank Guarantee Facility Agreement







National Australia Bank Limited



Reading Entertainment Australia Pty Ltd



Each Guarantor























































Corrs.com.au




Corrs Chambers Westgarth



Contents

EX-10.2·10-Q·CIK 716634·ACC 0000716634-26-000019·Filed May 17, 2026, 15:11 EDT

EX-10.1

EX-10.1

EXECUTION VERSION



TWELFTH AMENDMENT TO

SECOND AMENDED AND RESTATED CREDIT AGREEMENT



THIS TWELFTH AMENDMENT TO SECOND AMENDED AND RESTATED CREDIT

AGREEMENT (this “Twelfth Amendment”), dated to be effective as of February 27, 2026, is entered into by and among Consolidated Amusement Holdings, LLC, a Nevada limited liability company (the “Borrower”), the Affiliates of the Borrower identified on the signature pages hereto (collectively, the “Guarantors”), the financial institutions identified on the signature pages hereto (collectively, the “Lenders”), and Bank of America, N.A., as Administrative Agent, Swingline Lender and L/C Issuer, with reference to the following facts:

RECITALS

EX-10.1·10-Q·CIK 716634·ACC 0000716634-26-000019·Filed May 17, 2026, 15:11 EDT

EX-10.6

EX-10.6

SECOND AMENDED AND RESTATED

LIMITED LIABILITY COMPANY AGREEMENT

among

CONTEXTLOGIC HOLDINGS, LLC

and

THE MEMBERS NAMED HEREIN


Table of Contents

ARTICLE I DEFINITIONS 1
Section 1.01 Definitions 1
Section 1.02 Interpretation 11
ARTICLE II ORGANIZATION 12
Section 2.01 Formation 12
Section 2.02 Name 12
Section 2.03 Principal Office 12
Section 2.04 Registered Office; Registered Agent 12
Section 2.05 Purpose; Powers 12
Section 2.06 Term 12
Section 2.07 No State-Law Partnership; Tax Treatment 13
ARTICLE III UNITS 13
Section 3.01 Units Generally 13
Section 3.02 Authorization of Units 13
Section 3.03 Class A Convertible Preferred Units; Class B Common Units; Class P Units 13
Section 3.04 Conversion of Class A Convertible Preferred Units 14
Section 3.05 Other Issuances 14
Section 3.06 Preemptive Rights 15

EX-10.6·10-Q·CIK 2064307·ACC 0002064307-26-000004·Filed May 17, 2026, 15:11 EDT

EX-10.3

EX-10.3

FORBEARANCE AGREEMENT AND WAIVER TO CREDIT AGREEMENT

This FORBEARANCE AGREEMENT AND WAIVER TO CREDIT AGREEMENT, dated as of May 11, 2026 (this “May 2026 Waiver”), is entered into by and among Boxlight Corporation, a Nevada corporation (the “Borrower”), each Subsidiary of the Borrower listed as a “Guarantor” on the signature pages hereto (each a “Guarantor” and collectively, the “Guarantors”), the financial institutions party hereto as Lenders and Whitehawk Capital Partners LP (“Whitehawk Capital”), as the Administrative Agent.

EX-10.3·10-Q·CIK 1624512·ACC 0001628280-26-035695·Filed May 17, 2026, 15:01 EDT

EX-10.1

EX-10.1

STONERIDGE, INC.

2025 LONG-TERM INCENTIVE PLAN

SPECIAL PHANTOM SHARE GRANT AGREEMENT

January 31, 2026

Stoneridge, Inc., an Ohio corporation (the “Company”), pursuant to the terms and conditions hereof, hereby grants to [[FIRSTNAME]] [[LASTNAME]] (“Grantee”) the right to receive an amount of cash equal to the value of [[SHARESGRANTED]] Common Shares, without par value, of the Company (the “Phantom Shares”). The grant of Phantom Shares (the “Award”), as embodied by this Agreement (the “Agreement”), is described below.

1.    The Phantom Shares are in all respects subject to the terms, conditions and provisions of this Agreement and Stoneridge, Inc. 2025 Long-Term Incentive Plan (the “Plan”).

EX-10.1·10-Q·CIK 1043337·ACC 0001043337-26-000052·Filed May 17, 2026, 15:01 EDT

EX-10.38

EX-10.38

- 1 - TWELFTH AMENDING AGREEMENT THIS AGREEMENT made as of the 25 day of January, 2026 B E T W E E N : JERRY ZARCONE (hereinafter referred to as “Jerry”) - and – TARGET GROUP INC. (hereinafter referred to as “TGI”) - and – CANARY RX INC. (hereinafter referred to as “Canary”) - and – VISAVA INC. (hereinafter referred to as “Visava”) - and – CANNAKORP INC. (hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”) WHEREAS: A. Jerry and TGI entered into a Loan Agreement made as of the 20th day of December, 2019 (the “Loan Agreement”), which Loan Agreement has been amended and extended by various amending and extending agreements from time to time the most recent of is the Eleventh Amending Agreement made as of the 11th day of August, 2025 (collectively, the “FAEA”); B. All capitalized terms shall have the meanings ascribed to them in the FAEA unless otherwise defined herein; Docusign Envelope ID: 2BE13BF8-473F-450E-A95E-B7CBFCF35899

EX-10.38·10-Q·CIK 1586554·ACC 0001104659-26-062758·Filed May 17, 2026, 15:01 EDT